 |
APAvadis Biotechnologies S.r.l.
Exploring new technological tools to specifically target tumors through the bloodstream.
www.apavadis.com
|
 |
Bionucleon S.r.l.
Discovery of new oligo-based ligands against extracellular and membrane protein targets; improve the pharmacological behavior of oligonucleotidic ligands.
www.bionucleon.com
|
 |
Biopaint S.r.l.
Identifying and developing new ingredients to add to antifouling paints for the yachting industry.
www.biopaint.it
|
 |
Genovax S.r.l.
Development of:
- Vaccination system (through plasmids and proteins) for autoimmune diseases (lupus)
- A method for treating solid tumors based on peptides
www.genovax.it
|
 |
Narvalus S.r.l.
Single cell elctroporation and transfection technology.
www.narvalusbiotech.com
|
 |
Notopharm S.r.l.
Discovery and characterization of new biomarkers for the differential diagnosis of autoimmune diseases.
www.notopharm.com
|
 |
Spider Biotech S.r.l.
Discovery and development of therapeutic multimeric peptides and peptidomimetics in the fields of bacterial infections and the life-threatening conditions related (e.g. antibiotic resistance).
www.spiderbiotech.com
|
 |
Target Heart S.r.l.
Validate Melusin as a biopharmaceutical recombinant drug in preclinical studies on animal models of heart failure.
www.thbiotech.com
|
 |
Bioindustry Park Canavese S.p.A.
www.bioindustrypark.com
|
 |
Discovery
www.bioindustrypark.com/discovery
|
